The KOSDAQ CONNECT event will bring together over 100 KOSDAQ-listed companies, institutional investors, venture capitalists (VCs), and securities firms. Through this event, we plan to provide institutional investors with key updates on Orum’s proprietary Degrader Antibody Conjugate (DAC) platform and strategic business initiatives
Orum to participate in KOSDAQ CONNECT 2026
Previous
Previous
Orum to participate in Shinhan Bio Forum in Daejeon
Next
Next

